10-102230766-GCCCAGGCCCTGCAGGGC-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 12P and 4B. PVS1_StrongPP5_Very_StrongBS2
The ENST00000370002.8(PITX3):βc.640_656delβ(p.Ala214ArgfsTer42) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000397 in 1,510,390 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.000026 ( 0 hom., cov: 33)
Exomes π: 0.000041 ( 0 hom. )
Consequence
PITX3
ENST00000370002.8 frameshift
ENST00000370002.8 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.70
Genes affected
PITX3 (HGNC:9006): (paired like homeodomain 3) This gene encodes a member of the RIEG/PITX homeobox family, which is in the bicoid class of homeodomain proteins. Members of this family act as transcription factors. This protein is involved in lens formation during eye development. Mutations of this gene have been associated with anterior segment mesenchymal dysgenesis and congenital cataracts. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
PP5
Variant 10-102230766-GCCCAGGCCCTGCAGGGC-G is Pathogenic according to our data. Variant chr10-102230766-GCCCAGGCCCTGCAGGGC-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 468252.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-102230766-GCCCAGGCCCTGCAGGGC-G is described in Lovd as [Likely_pathogenic]. Variant chr10-102230766-GCCCAGGCCCTGCAGGGC-G is described in Lovd as [Pathogenic]. Variant chr10-102230766-GCCCAGGCCCTGCAGGGC-G is described in Lovd as [Pathogenic]. Variant chr10-102230766-GCCCAGGCCCTGCAGGGC-G is described in Lovd as [Pathogenic]. Variant chr10-102230766-GCCCAGGCCCTGCAGGGC-G is described in Lovd as [Likely_pathogenic]. Variant chr10-102230766-GCCCAGGCCCTGCAGGGC-G is described in Lovd as [Pathogenic].
BS2
High AC in GnomAdExome4 at 56 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PITX3 | NM_005029.4 | c.640_656del | p.Ala214ArgfsTer42 | frameshift_variant | 4/4 | ENST00000370002.8 | NP_005020.1 | |
PITX3 | XM_047425352.1 | c.640_656del | p.Ala214ArgfsTer42 | frameshift_variant | 3/3 | XP_047281308.1 | ||
GBF1 | NM_001391923.1 | c.-149_-133del | 5_prime_UTR_variant | 1/40 | NP_001378852.1 | |||
GBF1 | NM_001391924.1 | c.-287_-271del | 5_prime_UTR_variant | 1/41 | NP_001378853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PITX3 | ENST00000370002.8 | c.640_656del | p.Ala214ArgfsTer42 | frameshift_variant | 4/4 | 1 | NM_005029.4 | ENSP00000359019 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151964Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
151964
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000747 AC: 8AN: 107136Hom.: 0 AF XY: 0.000118 AC XY: 7AN XY: 59242
GnomAD3 exomes
AF:
AC:
8
AN:
107136
Hom.:
AF XY:
AC XY:
7
AN XY:
59242
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000412 AC: 56AN: 1358426Hom.: 0 AF XY: 0.0000433 AC XY: 29AN XY: 669416
GnomAD4 exome
AF:
AC:
56
AN:
1358426
Hom.:
AF XY:
AC XY:
29
AN XY:
669416
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151964Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74220
GnomAD4 genome
AF:
AC:
4
AN:
151964
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74220
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cataract 11 multiple types Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 19, 2024 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2023 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this premature translational stop signal affects PITX3 function (PMID: 30816539). This variant is present in population databases (no rsID available, gnomAD 0.01%). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 468252). This premature translational stop signal has been observed in individuals with congenital cataracts and/or Peter's anomalies (PMID: 30816539; Invitae). This sequence change creates a premature translational stop signal (p.Ala214Argfs*42) in the PITX3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 89 amino acid(s) of the PITX3 protein. - |
Anterior segment dysgenesis 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Mar 31, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with PITX3-related anterior segment dysgenesis and cataracts. (I) 0108 - This gene is associated with both recessive and dominant disease. This gene has mostly been associated with dominant disease, although rare cases of recessive inheritance have been reported, with homozygous individuals having a more severe phenotype (PMID: 21836522, PMID: 30816539, PMID: 29405783). (I) 0112 - The condition associated with this gene has incomplete penetrance (PMID: 30816539). (I) 0115 - Variants in this gene are known to have variable expressivity. A wide range of interfamilial and intrafamilial phenotypic variability has been reported. (PMID: 29405783). (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v2) <0.001 (8 heterozygotes, 0 homozygotes). (SP) 0600 - Variant is predicted to lose the OAR domain. The majority of reported pathogenic variants in PITX3 are predicted to result in the disruption of the OAR domain (PMID: 30894134). (I) 0702 - Other variants predicted to result in a truncated protein comparable to the one identified in this case have strong previous evidence for pathogenicity (ClinVar, PMID: 32830442). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. The variant has been previously reported in a homozygous patient with anterior segment dysgenesis and microphthalmia (PMID: 21836522) and heterozygous in at least four unrelated patients with congenital cataracts or Peters Anomaly (PMID: 30816539, PMID: 31848469, PMID: 33923544, PMID: 33304895). This variant has also been reported as a VUS in ClinVar. (SP) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Functional studies indicated that the mutant protein retained a nuclear localisation pattern but resulted in decreased transactivation activity (PMID: 30816539). (SP) 1206 - This variant has been shown to be paternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at